These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7726487)

  • 21. Structure-activity relations of 5,6-cis carbapenem antibiotics and role of factors determining susceptibility of Escherichia coli to beta-lactam antibiotics.
    Nozaki Y; Harada S; Kitano K; Imada A
    J Antibiot (Tokyo); 1984 Mar; 37(3):218-26. PubMed ID: 6373699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations.
    Fröhlich C; Gama JA; Harms K; Hirvonen VHA; Lund BA; van der Kamp MW; Johnsen PJ; Samuelsen Ø; Leiros HS
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Lactamases and susceptibility phenotypes to beta-lactam antibiotics in Escherichia coli strains.
    Roy C; Teruel D; Reig R; Hermida M; Teixell M
    J Antimicrob Chemother; 1992 May; 29(5):593-4. PubMed ID: 1624398
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro activity of beta-lactam antibiotics and their sensitivity to beta-lactamase].
    Esposito S; Galante D; Pennucci C; Scioli C
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1674-7. PubMed ID: 6365119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams.
    Mazzariol A; Cornaglia G; Nikaido H
    Antimicrob Agents Chemother; 2000 May; 44(5):1387-90. PubMed ID: 10770787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M; Pous-Miralles G; Romera-Sastre G; Panisello-Bertomeu JM; Jardí-Baiges AM; Zarazoga-López J
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
    Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.
    Agyekum A; Fajardo-Lubián A; Ai X; Ginn AN; Zong Z; Guo X; Turnidge J; Partridge SR; Iredell JR
    J Clin Microbiol; 2016 May; 54(5):1243-50. PubMed ID: 26912748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-lactamase types and beta-lactam resistance of Escherichia coli strains with chromosomally mediated ampicillin resistance.
    Marre R; Aleksic S
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):44-6. PubMed ID: 2406142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.